Capstan Therapeutics
About:
Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.
Website: https://www.capstantx.com
Twitter/X: capstantx
Top Investors: Alexandria Venture Investments, OrbiMed, RA Capital Management, Bristol-Myers Squibb, Perceptive Advisors
Description:
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
Total Funding Amount:
$340M
Headquarters Location:
San Diego, California, United States
Founded Date:
2021-01-01
Founders:
Haig Aghajanian
Number of Employees:
101-250
Last Funding Date:
2024-03-20
IPO Status:
Private
© 2025 bioDAO.ai